BridgeBio Pharma (BBIO) Non-cash Items (2018 - 2025)

BridgeBio Pharma's Non-cash Items history runs 8 years deep, the most recent figure standing at $9.7 million for Q2 2025.

• In Q2 2025, Non-cash Items fell 85.35% year-over-year to $9.7 million; the TTM figure through Jun 2025 stood at $9.7 million (down 85.35% YoY), while the FY2024 annual figure was $1.0 million, down 14.2% from the prior year.
• Non-cash Items came in at $9.7 million for Q2 2025 at BridgeBio Pharma, down from $130.9 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $146.3 million in Q3 2021 to a low of $314218.0 in Q1 2024.
• A 5-year average of $37.8 million and a median of $9.9 million in 2021 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items slumped 99.48% in 2023 and jumped 41548.47% in 2025, its largest moves.
• BridgeBio Pharma's Non-cash Items stood at $10.1 million in 2021, then slumped by 77.87% to $2.2 million in 2022, then jumped by 1306.06% to $31.6 million in 2023, then surged by 149.41% to $78.8 million in 2024, then slumped by 87.7% to $9.7 million in 2025.
• According to Business Quant data, Non-cash Items over the past three periods registered $9.7 million, $130.9 million, and $78.8 million for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison